Healthcare -
Biotechnology - NASDAQ - US
$ 6.7
-8.34 %
$ 70.1 M
Market Cap
0.07
P/E
AVTX - INTEREST INCOME & EXPENSE
Interest Income & Expense AVTX - Avalo Therapeutics, Inc.
3.42 M
LAST VALUE
19.55%
2 YEAR CAGR
0.00%
5 YEAR CAGR
78.25%
10 YEAR CAGR